Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Cancer02:18

Cancer

53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
What is Cancer?02:12

What is Cancer?

13.9K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer Vaccines01:30

Cancer Vaccines

946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.

CA: a cancer journal for clinicians·2026
Same author

Stat Bite: A reversal of esophageal cancer mortality between non-Hispanic Black and White individuals in the United States.

Journal of the National Cancer Institute·2026
Same author

Long-term trends in cancer mortality by rural-urban status, United States, 1969-2023.

Journal of the National Cancer Institute·2026
Same author

Colorectal cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

CA: a cancer journal for clinicians·2025
Same author

Stage-specific cancer survival in Black and White persons by urbanicity of county of residence, United States, 2015-2021.

Cancer·2025
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 14, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

637

Estadísticas del cáncer, 2026

Rebecca L Siegel1, Tyler B Kratzer1, Nikita Sandeep Wagle1

  • 1Surveillance, Prevention, and Health Services Research (SPHeRe), American Cancer Society, Atlanta, Georgia, USA.

CA: a cancer journal for clinicians
|January 13, 2026
PubMed
Resumen
Este resumen es generado por máquina.

Las proyecciones de incidencia y mortalidad del cáncer para 2026 muestran una disminución continua de las tasas de mortalidad del cáncer, con mejoras significativas en la supervivencia para muchos cánceres debido a la detección temprana y los avances en el tratamiento. Sin embargo, los recortes en la financiación de la investigación plantean una amenaza para el progreso futuro.

Palabras clave:
casos de cáncermortalidad por cáncerestadísticas del cáncerincidenciasupervivencia

Más Videos Relacionados

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

853
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

482

Videos de Experimentos Relacionados

Last Updated: Jan 14, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

637
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

853
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

482

Área de la Ciencia:

  • Oncología; Salud Pública; Epidemiología

Sus antecedentes:

  • La Sociedad Americana contra el Cáncer proporciona estimaciones anuales de casos y muertes por cáncer en los EE. UU.; Los datos se compilan de registros centrales de cáncer y del Centro Nacional de Estadísticas de Salud.; La incidencia y los resultados del cáncer se rastrean utilizando datos de incidencia (hasta 2022) y mortalidad (hasta 2023).

Objetivo del estudio:

  • Proyectar nuevos casos y muertes por cáncer para el año 2026.; Analizar las tendencias en las tasas de mortalidad por cáncer y la supervivencia.; Destacar el progreso en los resultados del cáncer e identificar amenazas para el avance continuo.

Principales métodos:

  • Utilización de datos poblacionales sobre incidencia y mortalidad del cáncer.; Análisis de tendencias en las tasas de mortalidad por cáncer y las tasas de supervivencia relativa a 5 años.; Comparación de las muertes proyectadas por cáncer en 2026 con datos históricos y otros tipos de cáncer.

Principales resultados:

  • Se proyectan aproximadamente 2.114.850 nuevos casos de cáncer y 626.140 muertes para 2026.; Las tasas de mortalidad por cáncer disminuyeron hasta 2023, evitando 4,8 millones de muertes desde 1991.; La supervivencia relativa general a 5 años alcanzó el 70% para los diagnósticos de 2015-2021, con ganancias notables para el mieloma, el hígado y el cáncer de pulmón.

Conclusiones:

  • Décadas de inversión científica han llevado a mejores tasas de supervivencia para muchos cánceres.; Se proyecta que el cáncer de pulmón cause más muertes que el cáncer colorrectal y pancreático combinados en 2026.; Los recortes propuestos a la investigación del cáncer y al seguro de salud amenazan el progreso futuro en la atención del cáncer.